Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure

References

Page 1

	Year	Citations
Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach Elizabeth R. DeLong, David M. DeLong, Daniel L. Clarke‐Pearson Biometrics EngineeringNew TestsGeneralizability TheoryStatistical FoundationDiagnosis	1988	21.5K
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC European Heart Journal	2012	6.9K
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond Michael J. Pencina, Ralph B. D' Agostino, Ralph B. D' Agostino, Statistics in Medicine	2007	6.2K
Guidelines for the diagnosis and treatment of chronic heart failure W. Remme European Heart Journal Heart FailureChronic Heart FailureStructural Heart DiseaseCardiovascular DiseaseCardiac Care	2001	1.6K
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Rudolf A. de Boer, Dirk J. Lok, Tiny Jaarsma, Annals of Medicine	2010	582
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice Tibor Kempf, Alexander Zarbock, Christian Widera, Nature Medicine InflammationThrombosisCardiovascular DiseaseBlood PlateletMedicine	2011	506
Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure Tibor Kempf, Stephan von Haehling, Timo Peter, Journal of the American College of Cardiology Growth Differentiation Factor-15Heart FailureChronic Heart FailureCardiovascular DiseaseCardiac Care	2007	485
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress Thomas J. Wang, Kai C. Wollert, Martin G. Larson, Circulation	2012	469
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Dirk J. Lok, Peter van der Meer, Pieta W. Bruggink‐André de la Porte, Clinical Research in Cardiology	2010	460
B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction Dirk J. van Veldhuisen, Gerard C.M. Linssen, Tiny Jaarsma, Journal of the American College of Cardiology Heart FailureHeart Failure PatientsCardiovascular DiseaseB-type Natriuretic PeptideDiuretic Resistance	2013	402

Page 1